Skip to main content

authID Inc.

For the period ended Sep 30, 2025. Filed Nov 12, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 12, 2025

AUID$0.18-2.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to Unaudited Condensed Consolidated Financial Statements

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – BASIS OF PRESENTATION

In the opinion of Management, the accompanying condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The results of operations for the nine months ended September 30, 2025 are not necessarily indicative of the results to be expected for future periods or the full year.

The consolidated financial statements include the accounts of authID Inc. and its wholly-owned subsidiaries MultiPay S.A.S. (dissolved as of August 2, 2024), ID Solutions, Inc., FIN Holdings Inc., Ipsidy Enterprises Limited, and authID Gaming Inc. (collectively the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

Going Concern

As of September 30, 2025, the Company had an accumulated deficit of approximately $187.7 million. For the nine months ended September 30, 2025, the Company earned net revenue of approximately $1.6 million, used approximately $11.8 million to fund its operations, and incurred a net loss of approximately $13.9 million.

The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition and acquiring new clients to generate revenues and cash flows. In April and May 2025, the Company raised a total of approximately $8.5 million after expenses from existing and new stockholders through the sale of Common Stock pursuant to registered direct offerings. Going forward, the Company plans to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms.

There is no assurance that the Company will ever be profitable. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

Net Loss per Common Share

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all potential dilutive common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2025 and 2024 because their effect was antidilutive:

Security20252024
Convertible notes payable-8,277
Warrants719,965697,446
Stock options2,463,4801,991,048
3,183,4452,696,771

Revenue Recognition

Revenues, net is defined as gross revenues, less discounts and sales concessions.

Software License– The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated. Variable fees are typically earned over time based on monthly users, transaction volumes or a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price. Transaction fees are billed monthly and are constrained to transactions incurred within the month.

For contracts with minimum annual fees, the Company generally recognizes the amount of revenue ratably over the contract year and records contract assets for the amount in excess of monthly contract billings relating to variable contract consideration. For certain contracts, the Company enters into an agreement which stipulates a minimum annual fee which is generally due at the end of the contract year, in excess of the amount of monthly billings. The Company may also require milestone payments of the minimum annual fee. The amount of any billed fees in excess of revenue recognized is recorded as deferred revenue. The Company accounts for price concessions as reductions to the transaction price under ASC 606. Price concessions represent implied or estimated future reductions in consideration that the Company expects to grant, based on known facts and circumstances, including customer usage patterns and strategic considerations. These concessions are treated as variable consideration and are included in the transaction price only to the extent that it is probable that a significant reversal of cumulative revenue will not occur when the uncertainty is resolved. During the three and nine months ended September 30, 2025, the Company granted approximately $0.7 million and $0.7 million in concessions, respectively.

Any usage-based fees in excess of the minimum contract amount are charged to the customer and allocated to the annual period in which they are earned under the contract. At the beginning of each annual period in the contract, the Company estimates the variable amounts for the annual period subject to the constrained variable consideration (usage-based fees) and recognizes that amount on a time-elapsed basis over the annual period. At each reporting date within an annual period, the Company reassesses its estimate of the excess variable amounts for the annual period and updates the amount recognized on a time-elapsed basis over the remainder of the annual period.

The Company had deferred revenue contract liabilities of approximately $0.01 million and $0.46 million as of September 30, 2025 and December 31, 2024, respectively, for certain revenue that will be earned in future periods.

Remaining Performance Obligations

As of September 30, 2025, the Company’s Remaining Performance Obligation (RPO) was $3.6 million, of which $0.5 million is held as deferred revenue and $3.1 million is related to other non-cancellable contracted amounts. This reflects a reduction in RPO of approximately $8.1 million from a customer contract under which partial payment was made during the three months ended September 30, 2025 but the customer requested amended terms before making further payments. The Company believes it is in its best interest to renegotiate terms with this customer, with whom we are continuing to work, and the parties are in discussions on renegotiating the contract. The Company expects approximately 48% of the RPO to be recognized as revenue over the next twelve months ending September 30, 2026 based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have sufficient historical information to estimate the timing of recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties.

Accounts Receivable and Contract Assets

All customers are granted credit on a short-term basis. Accounts receivable, net is stated net of the allowance for credit losses.

The Company maintains an allowance for its doubtful accounts receivable for estimated credit losses. This allowance is based upon historical loss patterns, the number of days that billings are past due, and evaluation of the potential risk of loss associated with delinquent accounts, current market conditions and reasonable and supportable forecasts of future billable product usage compared with contracted minimums. The Company records the allowance against bad debt expense through the condensed consolidated statement of operations, included in general and administrative expense, up to the amount of revenue recognized to date. Any incremental allowance is recorded as an offset to unearned revenue on the condensed consolidated balance sheet. Receivables are written off and charged against recorded allowance when the Company has exhausted collection efforts without success.

The Company evaluates its accounts receivable and contract assets balances using the Current Expected Credit Loss (“CECL”) model in accordance with ASC 326. The Company routinely reviews its accounts receivables and contract assets and uses a risk-based probability-weighted approach to record provisions. However, those provisions are estimates and actual results could differ from those estimates, and those differences may be material.

Changes in the allowance for credit losses are as follows:

Balance at December 31, 2024149,720
Provision for expected credit loss795,900
Credit loss write-offs(896,620)
Balance at September 30, 2025$49,000

Concentration of Risks

The Company’s financial instruments that are exposed to concentration of credit risks consist primarily of cash and accounts receivable. The Company’s cash at times may exceed the Federal Depository Insurance coverage of $250,000.

As of September 30, 2025, two customers accounted for 75% of the Company’s gross accounts receivable. As of December 31, 2024, three customers accounted for 49% of the Company’s accounts receivable.

The Company’s revenue is also exposed to concentration risk:

For the nine months ended September 30, 2025, one customer represented 48% of gross revenue.

For the three months ended September 30, 2025, two customers represented 47% of gross revenue.

For the nine months ended September 30, 2024, two customers represented 64% of gross revenue.

For the three months ended September 30, 2024, two customers represented 74% of gross revenue.

As of September 30, 2025, three customers accounted for 85% of the Company’s Remaining Performance Obligation.

As of December 31, 2024, one customer accounted for 70% of the Company’s Remaining Performance Obligation.

Deferred Contract Costs

We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. Reversals recorded in the nine months ended September 30, 2025 reflect commission claw-backs for certain bookings that were adjusted in the quarter, per our corporate policy. The following table summarizes deferred contract cost activity for the nine months ended September 30, 2025:

Deferred
Contract Costs
Carrying Value at December 31, 2024$617,918
Additions125,540
Reductions(455,072)
Amortization(57,842)
Carrying Value at September 30, 2025$230,544

NOTE 2 – OTHER CURRENT ASSETS

Other current assets consisted of the following at September 30, 2025 and December 31, 2024:

September 30,December 31,
20252024
Prepaid third-party and related party services$263,739$141,002
Prepaid insurance369,221319,190
Recoverable incentive compensation230,000-
Commissions advances121,392-
$984,352$460,192

Recoverable incentive compensation relates to recovery of approximately $230,000 in incentive payments made in prior periods that have subsequently been reduced based on adjustments to internal performance metrics. The recovery is expected to be made by December 2025 and the receivable is recorded as an asset .

NOTE 3 – INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

The Company’s intangible assets primarily consist of acquired and developed software that is being amortized over their estimated useful lives as indicated below. The following is a summary of activity related to intangible assets for the nine months ended September 30, 2025:

Acquired and
Developed
SoftwarePatentsTotal
Useful Lives · 5 Years · 10 Years
Carrying Value at December 31, 2024$99,819$113,899$213,718
Additions-1,7001,700
Amortization(62,713)(13,762)(76,475)
Carrying Value at September 30, 2025$37,106$101,837$138,943

The following is a summary of intangible assets as of September 30, 2025:

Acquired and
Developed
SoftwarePatentsTotal
Cost$1,782,872$185,596$1,968,468
Accumulated amortization(1,745,766)(83,759)(1,829,525)
Carrying Value at September 30, 2025$37,106$101,837$138,943

Amortization expense totaled approximately $76,000 and $131,000 for the nine months ended September 30, 2025, and 2024, respectively.

Future expected amortization of intangible assets is as follows:

2025 (Remainder of the Year)$10,824
202637,226
202730,442
202818,389
202918,389
Thereafter23,673
$138,943

There wereno impairment indicators noted with respect to Company’s long-lived assets, including intangible assets, as of September 30, 2025.

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consisted of the following as of September 30, 2025 and December 31, 2024:

September 30,December 31,
20252024
Trade payables$452,809$317,030
Accrued payroll and related obligations468,510984,536
Other accrued expenses354,027413,844
$1,275,346$1,715,410

NOTE 5 – CONVERTIBLE NOTES PAYABLE

On March 21, 2022, the Company entered into a Securities Purchase Agreement (“SPA”) with certain accredited investors, which included certain Company directors or their affiliates (the “Note Investors”). Under the SPA, the Company issued Senior Secured Convertible Notes (the “Convertible Notes”) to the Note Investors, with a total initial principal amount of approximately $9.2 million and a conversion price of $3.70 per share.

The Convertible Notes carried an aggregate cash origination fee of approximately $200,000, and the Company also issued approximately 3,562 shares of common stock to the Note Investors as an additional origination fee. These Convertible Notes matured on March 31, 2025 and accrued interest at an annual rate of 9.75%, was payable on a quarterly basis.

The following is a summary of convertible notes outstanding as of December 31, 2024:

December 31,
9.75% convertible notes due March 31, 2025$245,000
Less
Unamortized debt discount expense(652)
Unamortized debt issuance expense(3,464)
$240,884

The Company paid the outstanding Convertible Notes and accrued interest in full on March 31, 2025.

NOTE 6 – RELATED PARTY TRANSACTIONS

Commercial Agreements

On June 6, 2023, the Company entered into a services agreement with The Pipeline Group, Inc. (“TPG”). Ken Jisser, a director of the Company, is the founder and CEO of TPG, and Kunal Mehta, a director of the Company subsequently became an officer of TPG, a technology-enabled services company that aims to deliver business results for companies looking to build a predictable and profitable pipeline. The agreement provides that TPG will assist in providing outsourced sales including business development resources for outbound calling, provide support for automated dialing technology, classify customer data and other sales related services for an initial term of one year. On October 25, 2023, on December 19, 2023 and on August 26, 2024, the Company entered into amendments to the above services agreement, pursuant to which TPG will provide certain additional services to the Company. In consideration of the services, the Company paid TPG $70,000 per month. As of September 30, 2025, the Company held a balance of approximately $70,000 in prepaid expenses related to this service agreement. On September 26, 2025, the Company signed another amendment with TPG to reduce the monthly fees to $42,000. The amendment is effective October 1, 2025. Total expense incurred under this contract during the three and nine months ended September 30, 2025 was approximately $210,000 and $630,000, respectively. Total expense incurred under this contract during the three and nine months ended September 30, 2024 was approximately $210,000 and $752,000, respectively.

On September 30, 2025, the Company entered into a services agreement with TPG. The agreement provides that the Company will provide biometric authentication services to TPG for an initial term of two years, with an annual license fee of $2,500 and monthly minimum fees ramping to $1,000 per month.

Employment Agreement

Since June 2023, the Company has employed Dale Daguro, the brother of our CEO, Rhon Daguro as a VP Sales. Dale Daguro’s employment is at will and may be terminated at any time, with or without cause. Dale’s compensation is commensurate with other executives employed by the Company at a similar level of seniority and experience. During the three and nine months ended September 30, 2025, Dale Daguro earned approximately $77,000 and $227,000 in base salary and sales commission.

NOTE 7 –STOCKHOLDERS’ EQUITY

Common Stock

During the nine months ended September 30, 2025, shares of common stock were issued to recipients as a result of the following transactions:

●On April 1, 2025, pursuant to Securities Purchase Agreements in a registered direct offering, the Company issued 1,811,120 shares of common stock and pre-funded warrants for cash gross proceeds of approximately $8.2 million (or approximately $6.8 million, net of offering costs).
●On April 16, 2025, the Company issued 200,000 shares of common stock under restricted stock awards (“RSAs”) to non-employee advisors pursuant to advisory agreements.
●On May 7, 2025, pursuant to Securities Purchase Agreements in a registered direct offering, the Company issued 373,060 shares of common stock and pre-funded warrants for cash gross proceeds of approximately $2.1 million (or approximately $1.6 million, net of offering costs).
●The Company issued 27,838 shares in lieu of a cash severance payment at a price of $7.40 per share for a total value of $206,000.
●The Company issued 110,813 shares of common stock, upon the cashless exercise of warrants.

During the nine months ended September 30, 2024, shares of common stock were issued as a result of the following transactions:

●On June 27, 2024, pursuant to Securities Purchase Agreements in a registered direct offering, the Company issued 1,464,965 shares of common stock for cash gross proceeds of approximately $11.0 million (or approximately $10.0 million, net of offering costs).
●During the nine months ended September 30, 2024 the Company issued 5,724 shares of common stock, upon the cashless exercise of stock options.

Warrants

During the nine months ended September 30, 2025, warrants were issued as a result of the following transactions:

●On April 1, 2025, in connection with their placement agent services, the Company issued 91,556 common stock warrants to Dominari Securities, LLC, with a term of 5 years and an exercise price of $4.50 per share
●On April 1, 2025, in connection with their placement agent services, the Company issued 80,999 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $4.50 per share
●On May 7, 2025, in connection with their placement agent services, the Company issued 22,702 common stock warrants to Dominari Securities, LLC, with a term of 5 years and an exercise price of $5.60 per share
●On May 7, 2025, in connection with their placement agent services, the Company issued 14,762 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $5.60 per share

On April 22, 2025, Madison III, LLC exercised 187,500 warrants in a cashless exercise. The warrants were previously expensed at their fair value of $438,000.

On June 27, 2024, in connection with their placement agent services, the Company issued 102,547 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $7.50 per share.

The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2025:

Weighted · Weighted
Average · Average
Number ofExerciseRemaining
WarrantsPriceLife
Outstanding, December 31, 2024697,446$11.203.2 Years
Granted210,019$4.704.5 Years
Exercised/Cancelled(187,500)$3.16-
Outstanding, September 30, 2025719,965$11.403.0 Years

Restricted Stock Awards

On April 16, 2025, the Company granted 200,000 restricted stock awards (RSAs) at par value to non-employee advisors under advisory agreements. The awards were issued on the grant date and vest in four equal tranches of 50,000 shares each: (i) immediately upon execution of the advisory agreements on March 30, 2025, (ii) six months later, (iii) twelve months later, and (iv) eighteen months later. The Company has the option to repurchase all or a portion of unvested shares in the event that the advisors voluntarily cease to serve as an advisor of the Company. The fair value per share on the grant date was $7.97, resulting in a total grant-date fair value of $1,594,000. As of September 30, 2025, $797,000 of fair value was recognized as expense, with $797,000 of unrecognized compensation expense to be recognized through October 2026.

The following is a summary of the Company’s RSA activity for the nine months ended September 30, 2025:

Number of Restricted Stock AwardsWeighted Average Grant Date Fair Value Price
Outstanding, December 31, 2024 · - · $ · -
Granted200,000$7.97
Vested(100,000)$7.97
Outstanding, September 30, 2025200,000$7.97

Stock Options

During the nine months ended September 30, 2025,

●The Company granted directors a total of 357,361 options at an exercise price of $3.90 per share.
●The Company also granted a total of 416,600 options to certain new and existing employees at exercise prices ranging from $5.35 to $5.89 per share.
●During the nine months ended September 30, 2025, the Company granted a former employee 5,205 options at an exercise price of $7.40 in lieu of cash severance payment.

The Company determined the grant date fair value of options granted for the nine months ended September 30, 2025, using the Black Scholes Method, as applicable, with the following assumptions:

Expected volatility110 – 123%
Expected term2.5 – 5 years
Risk free rate3.65% – 4.59%
Dividend rate0.00%

Activity related to stock options for the nine months ended September 30, 2025, is summarized as follows:

Number of Shares · Weighted Average Exercise Price · Weighted Average Contractual Term (Yrs.) · Aggregate Intrinsic Value
Outstanding at December 31, 20242,147,402$20.896.3$1,146,540
Granted779,166$5.4110.0$-
Exercised-$--$-
Forfeited/cancelled(463,088)$42.682.3$-
Outstanding as of September 30, 20252,463,480$18.251.9$3,375
Exercisable as of September 30, 2025939,183$16.476.2$1,344

The following table summarizes stock option information as of September 30, 2025:

Weighted
Average
Contractual
Exercise PriceOutstandingTerm (Yrs.)Exercisable
$2.64 – $5.00701,7368.7293,389
$5.01 – $10.001,332,7908.6301,006
$10.01 – $15.0042,5781.142,578
$15.01 – $20.0043,7491.943,750
$20.01 – $121.28342,6274.1258,460
2,463,4807.8939,183

As of September 30, 2025, there was approximately $3.6 million of unrecognized compensation costs related to stock options outstanding that will be expensed through 2027.

On May 24, 2024, the Board of Directors adopted the 2024 Equity Incentive Plan (the “2024 Plan”). On June 26, 2024, the stockholders approved and ratified the 2024 Plan and the allocation of 395,000 shares of Common Stock to the 2024 Plan, in addition to the remaining shares not allocated to awards under the 2021 Equity Incentive Plan and any shares, which become available as a result of the forfeiture, or cancellation of any previous awards. On June 26, 2025, the stockholders approved and ratified an increase of 295,000 shares allocated to the 2024 Incentive Plan. As of September 30, 2025, there were 115,716 shares allocated to and available for issuance of awards under the 2024 Plan.

NOTE 8 – COMMITMENTS AND CONTINGENCIES

Legal Matters

From time to time the Company is a party to various legal or administrative proceedings arising in the ordinary course of our business. While any litigation contains an element of uncertainty, we have no reason to believe that the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

NOTE 9 – SEGMENT INFORMATION

Operating segments are defined as components of an enterprise for which separate financial information is available and which is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker (“CODM”) is the Chief Executive Officer. The CODM is the highest level of management responsible for assessing the Company’s overall performance, and making operational decisions such as resource allocations related to operations, product prioritization and delegations of authority. The CODM has determined that the Company operates in a single operating and reportable segment and manages segment profit (loss) based upon consolidated net income (loss). The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets.

NOTE 10 – SUBSEQUENT EVENTS

None.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.